|
Beryl Drugs Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
9.64 Cr.
|
P/BV
|
1.04
|
Book Value (Rs.)
|
18.30
|
|
52 Week High/Low (Rs.)
|
30/16
|
FV/ML
|
10/1
|
P/E(X)
|
16.66
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
1.14
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 7.89 | 8.07 |
| Other Operating Income | 0.48 | 0.06 |
| Total Income From Operations | 8.37 | 8.12 |
| | | |
| EXPENDITURE | | |
| Consumption of Raw Materials | 4.58 | 4.91 |
| Increase/Decrease in Stocks | 0.88 | 1.24 |
| Employees Cost | -0.04 | 0.34 |
| Depreciation | 0.05 | 0.20 |
| Other Expenses | 1.77 | 1.19 |
| Total Expenses | 7.24 | 7.87 |
| | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 1.13 | 0.25 |
| P/L Before Interest, Excpt. Items & Tax | 1.13 | 0.25 |
| Interest | -0.05 | 0.07 |
| P/L Before Exceptional Items & Tax | 1.18 | 0.18 |
| P/L Before Tax | 1.18 | 0.18 |
| Tax | 0.20 | 0.06 |
| P/L After Tax from Ordinary Activities | 0.98 | 0.12 |
| Extra Ordinary Item | 0.00 | 0.46 |
| Net Profit/Loss For the Period | 0.98 | 0.58 |
| Net P/L After Minority Interest & Share Of Associates | 0.98 | 0.58 |
| | | |
| Equity Share Capital | 5.07 | 5.07 |
| | | |
| PBITOE Margin (%) | 13.48 | 3.09 |
| PBTE Margin (%) | 14.13 | 2.24 |
| PBT Margin (%) | 14.13 | 2.24 |
| PAT Margin (%) | 11.69 | 7.10 |
| PAT After MI And SOA Margin (%) | 11.69 | 7.10 |
